GlassScriptPhysician profile
John L Cross
NPI 1770794695
$1,467.10
in general payments reported to CMS, 2019-2025
17 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,437 · 2021: $12.09 · 2023: $18.06.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $18.06.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $18.06 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $449.77 | 2019 | |
| Abbvie INC. | $312.97 | 2019 | |
| Novartis Pharmaceuticals Corporation | $266.78 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $92.26 | 2019 | |
| Celgene Corporation | $90.01 | 2019 | |
| Novo Nordisk INC | $66.35 | 2019 | |
| Sanofi-Aventis U.S. LLC | $25.79 | 2019 | |
| Ucb, INC. | $24.87 | 2019 | |
| Lilly USA, LLC | $23.18 | 2019 | |
| Pfizer INC. | $21.82 | 2019 | |
| Boston Scientific Corporation | $18.06 | 2023 | Rhythmia Mapping System |
| Hikma Pharmaceuticals USA | $15.01 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $14.18 | 2019 | |
| Apria Healthcare LLC | $12.09 | 2021 | |
| Kowa Pharmaceuticals America, INC. | $11.59 | 2019 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Takeda Pharmaceuticals U.S.A., INC. | $11.39 | 2019 | |
| Janssen Pharmaceuticals, INC | $10.98 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Cross listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.